UBS (CH) Equity Fund - Swiss Income (CHF) QL

Reference Data

ISIN CH0502155648
Valor Number 50215564
Bloomberg Global ID UBSICQC SW
Fund Name UBS (CH) Equity Fund - Swiss Income (CHF) QL
Fund Provider UBS Asset Management Switzerland AG, Zurich Basel, Switzerland
Phone: +41 61 288 75 01
E-Mail: sh-ubs-funds-feedback@ubs.com
Web: www.ubs.com/fonds
Fund Provider UBS Asset Management Switzerland AG, Zurich
Representative in Switzerland
Distributor(s) UBS Global Asset Management
Basel
Phone: +41 61 288 20 20
Asset Class Equities
EFC Category Equity Switzerland
Distribution Policy Distribution
Home Country Switzerland
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** This actively managed, diversified equity fund invests in Swiss equities that offer a high dividend yield The fund aims to generate additional income by selling call options on the stocks held in the fund. With this the fund aims to provide some downside cushion during market corrections and in return is expected to give up some upside during strongly rising equity markets The fund focuses on quality factors to exclude low quality stocks, including the company’s ability to pay stable or growing dividends The strategy is based on fundamental research The fund intends to distribute capital (premiums from writing call options) as well as income (e.g. from dividends).
Peculiarities

Fund Prices

Current Price * 96.17 CHF 12.11.2024
Previous Price * 97.50 CHF 11.11.2024
52 Week High * 99.72 CHF 18.10.2024
52 Week Low * 81.39 CHF 16.11.2023
NAV * 96.17 CHF 12.11.2024
Issue Price * 96.20 CHF 12.11.2024
Redemption Price * 96.20 CHF 12.11.2024
Closing Price *
Indicative Minimum Price
Fund Assets *** 2,017,962,491
Unit/Share Assets *** 654,596,881
Trading Information SIX

Performance

YTD Performance +14.42% 29.12.2023
12.11.2024
1 month -3.11% 14.10.2024
12.11.2024
3 months +0.98% 12.08.2024
12.11.2024
6 months +1.33% 13.05.2024
12.11.2024
1 year +18.98% 13.11.2023
12.11.2024
2 years +21.50% 14.11.2022
12.11.2024
3 years +11.31% 12.11.2021
12.11.2024
5 years +31.73% 12.11.2019
12.11.2024

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Novartis AG Registered Shares 9.54%
Roche Holding AG 9.41%
Nestle SA 9.05%
UBS Group AG 8.20%
Zurich Insurance Group AG 8.04%
ABB Ltd 7.06%
Givaudan SA 5.84%
Swiss Re AG 5.78%
Holcim Ltd 4.22%
Lonza Group Ltd 3.55%
Last data update 30.09.2024

Cost / Risk

TER 0.71%
TER date 31.10.2023
Performance Fee ***
PTR
Max. Management Fee *** 0.71%
Ongoing Charges *** 0.71%
SRRI ***
SRRI date *** 31.10.2024

ESG Fund Ratings

Low Carbon Designation ***
ESG Rating Overall ***
ESG Rating Corporate ***
ESG Rating Sovereign ***
% AuM H&S Controversies ***

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***

ESG Carbon Metrics

Avg Carbon Risk Score ***
Avg Carbon Risk Cat Avg ***
% AuM Covered Carbon ***
Avg Fossil Fuel Exposure ***
Fossil Fuel Cat Avg ***

ESG Strategy

Strategy Level 1 ***
Strategy Level 2 ***
Strategy Level 3 ***
Exclusions Level 1 ***
Exclusions Level 2 ***

* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)